These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 2464093

  • 1. Hemodynamic effects of beta-blocking compounds possessing vasodilating activity: a review of labetalol, prizidilol, and dilevalol.
    Lund-Johansen P.
    J Cardiovasc Pharmacol; 1988; 11 Suppl 2():S12-7. PubMed ID: 2464093
    [Abstract] [Full Text] [Related]

  • 2. Acute and chronic hemodynamic effects of drugs with different actions on adrenergic receptors: a comparison between alpha blockers and different types of beta blockers with and without vasodilating effect.
    Lund-Johansen P, Omvik P.
    Cardiovasc Drugs Ther; 1991 Jun; 5(3):605-15. PubMed ID: 1678963
    [Abstract] [Full Text] [Related]

  • 3. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
    Lund-Johansen P.
    Drugs; 1984 Jun; 28 Suppl 2():35-50. PubMed ID: 6151890
    [Abstract] [Full Text] [Related]

  • 4. Preclinical pharmacologic properties of dilevalol, an antihypertensive agent possessing selective beta 2 agonist-mediated vasodilation and beta antagonism.
    Sybertz EJ, Watkins RW.
    Am J Cardiol; 1989 Jun 05; 63(19):3I-6I. PubMed ID: 2567112
    [Abstract] [Full Text] [Related]

  • 5. Dilevalol: a selective beta-2 adrenergic agonist vasodilator with beta adrenergic blocking activity.
    Wallin JD, Frishman WH.
    J Clin Pharmacol; 1989 Dec 05; 29(12):1057-68. PubMed ID: 2693499
    [Abstract] [Full Text] [Related]

  • 6. Hemodynamic changes after acute and long-term combined alpha--beta-adrenoceptor blockade with labetalol as compared with beta-receptor blockade.
    Koch G.
    J Cardiovasc Pharmacol; 1981 Dec 05; 3 Suppl 1():S30-41. PubMed ID: 6169958
    [Abstract] [Full Text] [Related]

  • 7. The influence of vasodilating beta-blockers on cardiac function and vascular resistance in essential hypertension.
    Lund-Johansen P.
    Clin Nephrol; 1992 Dec 05; 38 Suppl 1():S78-86. PubMed ID: 1363538
    [Abstract] [Full Text] [Related]

  • 8. Prizidilol in essential hypertension: long-term effects on plasma volume, extracellular fluid volume, and central hemodynamics at rest and during exercise.
    Lund-Johansen P, Omvik P.
    J Cardiovasc Pharmacol; 1982 Dec 05; 4(6):1012-7. PubMed ID: 6185765
    [Abstract] [Full Text] [Related]

  • 9. Role of beta 2-receptor stimulation in the peripheral vascular actions of the antihypertensive dilevalol.
    Watkins RW, Sybertz EJ, Cook J, Pula K, Cedeno K, Tedesco RP, McLeod R.
    Arch Int Pharmacodyn Ther; 1989 Dec 05; 302():158-73. PubMed ID: 2576892
    [Abstract] [Full Text] [Related]

  • 10. Pharmacology of combined alpha-beta-blockade. I.
    Louis WJ, McNeil JJ, Drummer OH.
    Drugs; 1984 Dec 05; 28 Suppl 2():16-34. PubMed ID: 6151889
    [Abstract] [Full Text] [Related]

  • 11. Experimental and clinical pharmacology of carvedilol and other drugs combining vasodilation and beta-adrenoceptor antagonism in a single molecule.
    Strein K, Sponer G.
    Z Kardiol; 1990 Dec 05; 79 Suppl 3():89-98. PubMed ID: 1983054
    [Abstract] [Full Text] [Related]

  • 12. The dose dependency of the alpha-adrenoceptor antagonist and beta-adrenoceptor partial agonist activity of dilevalol and labetalol in man.
    Tham TC, McKaigue JP, Guy S, Shanks RG, Riddell JG.
    Br J Clin Pharmacol; 1993 Sep 05; 36(3):251-6. PubMed ID: 9114912
    [Abstract] [Full Text] [Related]

  • 13. Effects of dilevalol on rest and supine exercise hemodynamics in mild to moderate systemic hypertension.
    Bugni WJ, Ayers CW, Ashby R, Bittle PA, Ramirez G.
    Am J Cardiol; 1989 Feb 15; 63(7):452-6. PubMed ID: 2563624
    [Abstract] [Full Text] [Related]

  • 14. Beta-adrenoceptor blockade and vasodilatation in essential hypertension. Hemodynamic studies at rest and during exposure to stress.
    Eggertsen R.
    Acta Med Scand Suppl; 1984 Feb 15; 689():1-46. PubMed ID: 6151343
    [Abstract] [Full Text] [Related]

  • 15. The role of multiple action agents in hypertension.
    Lund-Johansen P, Omvik P.
    Eur J Clin Pharmacol; 1990 Feb 15; 38 Suppl 2():S89-95. PubMed ID: 1974512
    [Abstract] [Full Text] [Related]

  • 16. Differential hemodynamic effects of beta-adrenoceptor blockers, Ca antagonists and combined alpha-beta-receptor blockade in ischemic heart disease.
    Koch G.
    Acta Med Scand; 1986 Feb 15; 219(1):17-22. PubMed ID: 2869648
    [Abstract] [Full Text] [Related]

  • 17. Actions of dilevalol on adrenoceptors.
    Louis WJ, Drummer OH, Tung LH.
    J Cardiovasc Pharmacol; 1988 Feb 15; 11 Suppl 2():S5-11. PubMed ID: 2464095
    [Abstract] [Full Text] [Related]

  • 18. Beta-blocking agents with vasodilating action.
    Prichard BN.
    J Cardiovasc Pharmacol; 1992 Feb 15; 19 Suppl 1():S1-4. PubMed ID: 1378133
    [Abstract] [Full Text] [Related]

  • 19. Dilevalol: an overview of its clinical pharmacology and therapeutic use in hypertension.
    Lalonde RL, Tenero DM, Kazierad DJ.
    Pharmacotherapy; 1990 Feb 15; 10(1):15-28. PubMed ID: 2179899
    [Abstract] [Full Text] [Related]

  • 20. Effects of dilevalol, an R, R-isomer of labetalol, on blood pressure and renal function in patients with mild-to-moderate essential hypertension.
    Baba T, Murabayashi S, Aoyagi K, Ishizaki T.
    Eur J Clin Pharmacol; 1988 Feb 15; 35(1):9-15. PubMed ID: 2905992
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.